June 14, 2024
6/14/2024 La Paix contains hidden drug ingredient 1/30/2024 Arize contains hidden drug ingredient 1/30/2024 Schwinnng contains hidden drug ingredient 1/30/2024 Sustain® contains hidden drug ingredients 1/2/2024 […]
June 14, 2024
[6-14-2024] The Food and Drug Administration is advising consumers not to purchase or use La Paix, a product promoted and sold for sexual enhancement on various […]
June 14, 2024
[6-14-2024] The Food and Drug Administration is advising consumers not to purchase or use Umary, a product promoted and sold for pain on various websites, including https://www.solovital.com […]
June 14, 2024
Despite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) still struggle to reach remission even after […]
June 14, 2024
Docket Number: FDA-2023-D-4067 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research The Food and Drug Administration (FDA or Agency) is announcing the availability […]
June 14, 2024
Advances in breast cancer detection and treatment over the past decades have led to an increase in the number of women diagnosed at earlier stages and […]
June 14, 2024
Docket Number: FDA-2022-D-0235 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research This guidance provides recommendations to assist industry in the development of oligonucleotide […]
June 14, 2024
NASHVILLE, Tennessee — For the first time, the majority of patients with multiple sclerosis (MS) in the United States are, or soon will be, over age […]
June 14, 2024
VIENNA — Results from the phase 3 SELECT-GCA study showed that the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) induces significant and sustained remission in people with […]